Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia

被引：0

作者：

Carey-Smith, Shannon L. ^{[1
]}

Simad, Maryam H. ^{[1
]}

Panchal, Kunjal ^{[1
,2
]}

Aya-Bonilla, Carlos ^{[1
]}

Smolders, Hannah ^{[1
]}

Lin, Sang ^{[1
]}

Armitage, Jesse D. ^{[1
]}

Nguyen, Vivien T. ^{[1
]}

Bentley, Kathryn ^{[1
]}

Ford, Jette ^{[1
]}

Singh, Sajla ^{[1
]}

Oommen, Joyce ^{[1
]}

Laurent, Anouchka P. ^{[3
]}

Mercher, Thomas ^{[3
]}

Crispino, John D. ^{[4
]}

Montgomery, Andrew P. ^{[5
]}

Kassiou, Michael ^{[5
]}

Besson, Thierry ^{[6
]}

Deau, Emmanuel ^{[7
]}

Meijer, Laurent ^{[7
]}

Cheung, Laurence C. ^{[1
,2
,8
]}

Kotecha, Rishi S. ^{[1
,2
,9
,10
]}

Malinge, Sebastien ^{[1
,2
,10
]}

机构：

[1] Telethon Kids Inst, Telethon Kids Canc Ctr, Perth, WA, Australia

[2] Curtin Univ, Curtin Med Sch, Perth, WA, Australia

[3] INSERM, U1170, Gustave Roussy, Villejuif, France

[4] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN USA

[5] Univ Sydney, Sch Chem, Sydney, NSW, Australia

[6] Univ Rouen Normandie, INSA Rouen Normandie, CNRS, COBRA UMR 6014, Rouen, France

[7] Perha Pharmaceut, Roscoff, France

[8] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA, Australia

[9] Perth Childrens Hosp, Dept Clin Haematol Oncol Blood & Marrow Transplant, Perth, WA, Australia

[10] Univ Western Australia, Perth, WA, Australia

来源：

REVISTA CHILENA DE LITERATURA | 2024年 / 109期

关键词：

CHILDREN;

D O I：

暂无

中图分类号：

I3/7 [各国文学];

学科分类号：

摘要：

引用

页码：2309 / 2315

页数：7

共 50 条

[41] DYRK1A Kinase Inhibitors with Emphasis on Cancer
Ionescu, A.
Dufrasne, F.
Gelbcke, M.
Jabin, I.
Kiss, R.
Lamoral-Theys, D.
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2012, 12 (13) : 1315 - 1329
[42] DYRK1a Inhibitor Mediated Rescue of Drosophila Models of Alzheimer's Disease-Down Syndrome Phenotypes
Zhu, Bangfu
Parsons, Tom
Stensen, Wenche
Svendsen, John S. Mjoen
Fugelli, Anders
Hodge, James J. L.
FRONTIERS IN PHARMACOLOGY, 2022, 13
[43] Recent research and development of DYRK1A inhibitors
Liyun Zhao
Xuan Xiong
Li Liu
Qi Liang
Rongsheng Tong
Xuanlin Feng
Lan Bai
Jianyou Shi
ChineseChemicalLetters, 2022, 33 (04) : 1841 - 1849
[44] Triplication of DYRK1A causes retinal structural and functional alterations in Down syndrome
Laguna, Ariadna
Barallobre, Maria-Jose
Marchena, Miguel-Angel
Mateus, Catarina
Ramirez, Erika
Martinez-Cue, Carmen
Delabar, Jean M.
Castelo-Branco, Miguel
de la Villa, Pedro
Arbones, Maria L.
HUMAN MOLECULAR GENETICS, 2013, 22 (14) : 2775 - 2784
[45] A commentary on: Overexpression of Dyrk1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome
Dierssen, Mara
EXPERIMENTAL NEUROLOGY, 2013, 247 : 110 - 112
[46] DYRK1a Inhibitor Mediated Rescue of Drosophila Models of Alzheimer's Disease-Down Syndrome Phenotypes
Zhu, Bangfu
Parsons, Tom
Stensen, Wenche
Mjoen Svendsen, John S.
Fugelli, Anders
Hodge, James J. L.
FRONTIERS IN PHARMACOLOGY, 2022, 13
[47] Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models
Ferrer, I
Barrachina, M
Puig, B
de Lagrán, MM
Martí, E
Avila, J
Dierssen, M
NEUROBIOLOGY OF DISEASE, 2005, 20 (02) : 392 - 400
[48] Discovery of novel benzothiophene derivatives as potent and narrow spectrum inhibitors of DYRK1A and DYRK1B
Segretti, Natanael D.
Takarada, Jessica E.
Ferreira, Marcos A., Jr.
Santiago, Andre da Silva
Teodoro, Bruno V. M.
Damiao, Mariana C. F. C. B.
Godoi, Paulo H.
Cunha, Micael R.
Fala, Angela M.
Ramos, Priscila Z.
Ishikawa, Eloisa E.
Mascarello, Alessandra
Serafim, Ricardo A. M.
Azevedo, Hatylas
Guimaraes, Cristiano R. W.
Counago, Rafael M.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 68
[49] The Chromosome 21 Kinase DYRK1A Controls Cell Cycle Exit and Survival During Lymphoid Development and Is a Novel Therapeutic Target In Acute Lymphoblastic Leukemia
Thompson, Benjamin J.
Diebold, Lauren
Malinge, Sebastien
Leblond, Bertrand
Casagrande, Anne-Sophie
Desire, Laurent
Foucourt, Alicia
Besson, Thierry
Hijiya, Nobuko
Crispino, John D.
BLOOD, 2013, 122 (21)
[50] DYRK1A Is Regulated By Oncogenic KMT2A and Required for Survival of KMT2A-Rearranged Acute Lymphoblastic Leukemia
Hurtz, Christian
Wertheim, Gerald
Bhansali, Rahul S.
Lehman, Anne
Jeschke, Grace
Crispino, John D.
Besson, Thierry
Tasian, Sarah K.
Carroll, Martin
BLOOD, 2019, 134

← 1 2 3 4 5 →